The global Ultomiris Drug Market is poised for significant expansion between 2025 and 2033, driven by increasing demand for advanced treatments for rare and life-threatening disorders. Valued at approximately USD 5.2 billion in 2025, the market is projected to reach USD 14.9 billion by 2033, registering a compound annual growth rate (CAGR) of 14.4% during the forecast period.
Ultomiris, also...